Do you live with ALK-positive lung cancer and want to share your experience to help shape how care and support could be better? There is an opportunity to take part in a small patient advisory board in Vienna on Tuesday 21 April 2026 (the day before the Lung Cancer Europe conference).
This is a structured conversation with a pharmaceutical partner, intended to listen directly to real patient experiences and treatment preferences. It is not a promotional session, and you do not need to “represent” anyone but yourself.
Who are they looking for?
- People living with ALK-positive lung cancer
- Participants from a range of European countries
- You can take part in the conversation in English
- Group size: approximately 10–12 people
Practical information
- When: Tuesday 21 April 2026, in the afternoon
- Duration: approximately 2 hours
- Where: Vienna
- Compensation: travel and hotel costs are reimbursed, plus a €100 payment as a thank-you
- You can take part even if you are not attending the conference
Interested? Get in touch
Would you like to be considered? Send us a message and briefly mention:
- Which country you live in
- That you live with ALK-positive lung cancer
- That you can follow the conversation comfortably in English
If it looks like a good match, we can recommend you to the organisers, so that you can receive the official invitation and full details.
Your experience counts — and this is a concrete way to make ALK-positive voices heard.